Question

question 9

a pharmacy technician is repackaging bulk medications into unit-dose packaging. the technician should recognize that which of the following actions is required to maintain compliance with usp standards?

use the original manufacturer expiration date as the beyond-use date for repackaged products.
repackage medications in any available container without regard to light sensitivity.
repackage medications under a standard lafw without additional documentation.
document the repackaging process including

Explanation:

Analyze the requirements for repackaging bulk medications

Using the USP Standards and Unit Dose Labeling knowledge points, repackaging bulk medications into unit-dose packaging requires strict adherence to quality control, labeling, and record-keeping guidelines to ensure patient safety and traceability.

Evaluate the first option

Using the USP Standards knowledge point, the beyond-use date (BUD) for repackaged nonsterile solid and liquid oral dosage forms is typically 1 year from the repackaging date or the manufacturer's expiration date, whichever is earlier. Therefore, using the original manufacturer's expiration date directly without applying the BUD rule is incorrect.

Evaluate the second and third options

Using the USP Standards and Institutional Packaging knowledge points, medications must be repackaged in containers that protect them from environmental factors like light and moisture. Furthermore, repackaging is a regulated process that cannot be done without detailed documentation.

Evaluate the fourth option

Using the USP Standards and Unit Dose Labeling knowledge points, a complete repackaging log must be maintained. This documentation must include the drug name, strength, manufacturer, lot number, expiration date, repackager's identity, date of repackaging, quantity repackaged, and the assigned beyond-use date to ensure full traceability.

Answer:

• (A) Use the original manufacturer expiration date as the beyond-use date for repackaged products.
• (B) Repackage medications in any available container without regard to light sensitivity.
• (C) Repackage medications under a standard LAFW without additional documentation.
• (D) Document the repackaging process including (Correct answer)